View Archive »
About The Cover
The cover for issue 57 of Oncotarget features Figure 1A, "Schematic representation of our systematic approach developed to identify effective compounds and biological vulnerabilities in EwS.," by Tsafou, et al.
|
|
Table of Contents
News
|
| Modification of the tumour microenvironment via exosomal shedding of sphingosine 1phosphate receptor 2 by breast cancer cells |
|
https://doi.org/10.18632/oncotarget.25793
|
| 30938-30939 |
Editorial
|
| The vulnerability of RB loss in breast cancer: Targeting a void in cell cycle control |
|
https://doi.org/10.18632/oncotarget.25797
|
| 30940-30941 |
|
| Expedited approval of cancer drugs without randomized controlled trials: Too good to be true |
|
https://doi.org/10.18632/oncotarget.25799
|
| 30942-30943 |
|
| Metastability an emerging concept governing BOKmediated apoptosis initiation |
|
https://doi.org/10.18632/oncotarget.25801
|
| 30944-30945 |
Research Papers
|
| Patient derived renal cell carcinoma xenografts exhibit distinct sensitivity patterns in response to antiangiogenic therapy and constitute a suitable tool for biomarker development |
|
https://doi.org/10.18632/oncotarget.25697
|
| 30946-30961 |
|
| Cellspecific plasticity associated with integrative memory of triple sensory signals in the barrel cortex |
|
https://doi.org/10.18632/oncotarget.25740
|
| 30962-30978 |
|
| Increased expression of the thyroid hormone nuclear receptor TRα1 characterizes intestinal tumors with high Wnt activity |
|
https://doi.org/10.18632/oncotarget.25741
|
| 30979-30996 |
|
| Impact of cell fusion in myeloma marrow microenvironment on tumor progression |
|
https://doi.org/10.18632/oncotarget.25742
|
| 30997-31006 |
|
| Comparative proteomics of soluble factors secreted by human breast adipose tissue from tumor and normal breast |
|
https://doi.org/10.18632/oncotarget.25749
|
| 31007-31017 |
|
| Identifying the druggable interactome of EWSFLI1 reveals MCL1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers |
|
https://doi.org/10.18632/oncotarget.25760
|
| 31018-31031 |
|
| High Olinked Nacetylglucosamine transferase expression predicts poor survival in patients with early stage lung adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.25772
|
| 31032-31044 |
|
| Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta24RGD infection |
|
https://doi.org/10.18632/oncotarget.25774
|
| 31045-31065 |
|
| A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutations |
|
https://doi.org/10.18632/oncotarget.25779
|
| 31066-31076 |
|
| STAT3 is constitutively activated in chronic active EpsteinBarr virus infection and can be a therapeutic target |
|
https://doi.org/10.18632/oncotarget.25780
|
| 31077-31089 |
|
| CXC Motif Ligand 1 CXCL1 from melanoma cells downregulates the invasion of their metastatic melanoma cells |
|
https://doi.org/10.18632/oncotarget.25783
|
| 31090-31097 |
|
| Stim and Orai mediate constitutive Ca2+ entry and control endoplasmic reticulum Ca2+ refilling in primary cultures of colorectal carcinoma cells |
|
https://doi.org/10.18632/oncotarget.25785
|
| 31098-31119 |
|
| Lung cancer susceptibility from GSTM1 deletion and air pollution with smoking status: a metaprediction of worldwide populations |
|
https://doi.org/10.18632/oncotarget.25693
|
| 31120-31132 |
Clinical Research Papers
|
| Screening for distress in patients with intracranial tumors during the first 6 months after diagnosis using selfreporting instruments and an expert rating scale the basic documentation for psychooncology short form – POBado SF |
|
https://doi.org/10.18632/oncotarget.25763
|
| 31133-31145 |
Reviews
|
| Helicobacter pylori associated factors in the development of gastric cancer with special reference to the earlyonset subtype |
|
https://doi.org/10.18632/oncotarget.25757
|
| 31146-31162 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
